Oxitec Pioneered the GM Mosquito. Up Next? Moths, of Course
By Eric Niiler,
Wired
| 05. 10. 2017
A HALF-INCH-LONG MOTH that devours kale, broccoli, and Brussels sprouts may not inspire the same fear as a Zika-carrying mosquito, but the two insects have something in common. Both are being genetically tweaked by UK-based biotech firm Oxitec. Last year, the company made news when it proposed a Florida-based trial of a self-destructive mosquito—designed to stop the spread of Zika virus in native Aedes aegypti mosquitoes.
Now, Oxitec wants to test a genetically modified version of the male diamondback moth to mate with—and eventually destroy—a pest that damages $5 billion worth of cruciferous crops every year worldwide. Like the mosquito, the moth passed laboratory and greenhouse trials and now must pass approval in a open field test. But while the mosquito had to wind its way through the FDA, Oxitec’s moth faces a different set of regulatory hurdles at the USDA. Officials at that agency are currently reviewing whether to allow Cornell University and Oxitec to release tens of thousands of GM moths into a 10-acre site in New York.
For decades, agricultural researchers have battled insect pests that are growing...
Related Articles
By Adithi Ramakrishnan, AP News | 08.05.2026
NEW YORK (AP) — Matt Walker couldn’t pet a dog without sneezing — until he and other scientists used a gene editing technique to produce a hypoallergenic beagle named Bailey.
Now, he can feed Bailey spoons of peanut butter while...
By Jessica Hamzelou, MIT Technology Review | 07.23.2026
When it comes to organ donation, time is everything. As soon as an organ has been carefully removed from a donor’s body, it starts to deteriorate. Surgeons have a matter of hours to get it into a recipient. Leave...
By Carissa Wong, New Scientist | 07.08.2026
Healthy lambs have been born via an experimental form of in vitro fertilisation (IVF) that coaxes highly immature eggs to become mature ones in the lab. This is the first time the approach has been demonstrated in a large animal...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...